| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/21/2004 | CN1514712A Nial Compositions and methods of administering same |
| 07/21/2004 | CN1514706A Therapeutic film forming composition and treatment system |
| 07/21/2004 | CN1513549A Polythylene glycol-interferon alpha foreeze dried preparation |
| 07/21/2004 | CN1513547A Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue |
| 07/21/2004 | CN1513499A Process for preparing capsule for invigorating circulation of blood and relieving pain |
| 07/21/2004 | CN1513439A Slow release medicine of pseudo-ephedrine hydrochloride |
| 07/21/2004 | CN1158107C Pharmaceutical compositions contg. platelet aggregation inhibitors |
| 07/21/2004 | CN1158084C Long-acting heparin intraocular slow-released system |
| 07/21/2004 | CN1158075C Pharmaceutical compsn. and process for its prepn. |
| 07/21/2004 | CN1158072C Granulate with high content of L-carnitine or alkanoyl L-carnitine suitable for preparing tablets by pressing directly |
| 07/21/2004 | CN1158071C Multi-layered osmotic device |
| 07/21/2004 | CN1158070C Immediate release tablet |
| 07/21/2004 | CN1158069C Antibacterial oil-in-water emulsions |
| 07/21/2004 | CN1158068C Polyol/oil suspensions for the sustained release of proteins |
| 07/21/2004 | CN1158057C Forming medicine pills in water contg. active compound melt material |
| 07/20/2004 | USRE38558 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 07/20/2004 | US6765072 Process for the preparation of aqueous dispersions of latex particles having a heterogeneous morphology, the latex particles obtainable with the process, the dispersions and redispersible powders, as well as the use thereof |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765014 1-Acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 07/20/2004 | US6765007 High-content famciclovir tablets |
| 07/20/2004 | US6765001 Mixture with penetration intensifiers, solvents and emulsifiers |
| 07/20/2004 | US6764997 Admixture of azithromycin and a stabilizing-effective amount of an antioxidant to improve the resistance of the azithromycin to degradation; for therapy of bacterial infection in a human or non- human animal |
| 07/20/2004 | US6764993 Use of o-vanillin and o-vanillin/trolox combinations |
| 07/20/2004 | US6764845 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 07/20/2004 | US6764698 Controlled drug release system of retinoic acid |
| 07/20/2004 | US6764696 Effervescent drug delivery system for oral administration |
| 07/20/2004 | US6764690 Drug delivery |
| 07/20/2004 | US6764682 Adjuvant compositions containing more than one adjuvant |
| 07/20/2004 | US6764680 Administering monoclonal antibodies |
| 07/20/2004 | US6763607 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 07/20/2004 | CA2408633C Management of snoring by oral administration of dimethyl sulfone |
| 07/20/2004 | CA2396927C Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 07/20/2004 | CA2346320C Aqueous-centre microcapsules containing at least one water-soluble, cosmetic or dermatological active ingredient and cosmetic or dermatological compositions containing them |
| 07/20/2004 | CA2246456C Lipids and their use, for example, in liposomes |
| 07/20/2004 | CA2107683C Immobilization of chemical species in crosslinked matrices |
| 07/15/2004 | WO2004058988A2 Binding agents which inhibit myostatin |
| 07/15/2004 | WO2004058842A1 Method for the production of an active molecule vector used to diffuse active substances and vector thus obtained |
| 07/15/2004 | WO2004058813A2 Peptides having a high cysteine content |
| 07/15/2004 | WO2004058803A2 Peptides that bind of the vegfr-2 |
| 07/15/2004 | WO2004058802A1 Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
| 07/15/2004 | WO2004058697A1 4-nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivates and their pharmaceutical use |
| 07/15/2004 | WO2004058309A1 Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof |
| 07/15/2004 | WO2004058308A1 An efficient non-viral gene/drug delivery system |
| 07/15/2004 | WO2004058303A2 Compositions of benzoquinolizine carboxylic acid antibiotic drugs |
| 07/15/2004 | WO2004058286A1 Administration of capsaicinoids |
| 07/15/2004 | WO2004058273A1 Use of rimexolone in the treatment of dry eye |
| 07/15/2004 | WO2004058261A1 Antibacterial water-based preparation |
| 07/15/2004 | WO2004058256A1 Pharmaceutical liquid composition containing pyridone derivative |
| 07/15/2004 | WO2004058221A1 Dosing aerosols containing lecithin as a surface-active substance |
| 07/15/2004 | WO2004058220A1 Improved nail drug delivery composition |
| 07/15/2004 | WO2004058143A2 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 07/15/2004 | WO2004057959A2 Intracutaneous injection |
| 07/15/2004 | WO2004045537A3 Edible film for relief of cough or symptoms associated with pharyngitis |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004043390A3 Pharmaceutical compositions and methods of using taxane derivatives |
| 07/15/2004 | WO2004041245A3 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 07/15/2004 | WO2004041187A3 Compositions and methods for transdermal oxybutynin therapy |
| 07/15/2004 | WO2004041158A3 Rifalazil compositions and therapeutic regimens |
| 07/15/2004 | WO2004034967A3 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety |
| 07/15/2004 | WO2004030650A3 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 07/15/2004 | WO2004027045A3 Polymer-linker-drug conjugates for targeted drug delivery |
| 07/15/2004 | WO2004019878A3 Adzymes and uses thereof |
| 07/15/2004 | WO2003101404A3 Preparations for topical skin use and treatment |
| 07/15/2004 | WO2003101357A9 Transmucosal delivery of cannabinoids |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003092626A3 Carvedilol pharmasolve solvate |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003087195A3 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them |
| 07/15/2004 | WO2003080079B1 Use of sulfoalkyl ether cyclodextrin as a preservative |
| 07/15/2004 | WO2003015694A3 Agents for enhancing the immune response |
| 07/15/2004 | WO2002072811A3 Human prenylcysteine lyase-like protein |
| 07/15/2004 | US20040138299 Dispersion of bicalutamide for prostate cancer treatment |
| 07/15/2004 | US20040138293 Pharmaceutical composition made of cannabis extracts |
| 07/15/2004 | US20040138290 Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium |
| 07/15/2004 | US20040138237 Novel injectable depot formulations |
| 07/15/2004 | US20040138231 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropyl-methylcellulose phthalate polymer |
| 07/15/2004 | US20040138179 Antifungal formulations |
| 07/15/2004 | US20040138171 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 07/15/2004 | US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor |
| 07/15/2004 | US20040138165 Nucleic acids; drug or gene product; stabilization; gene therapy; purification using free radical scavenger |
| 07/15/2004 | US20040138155 for treatment of central and/or peripheral nervous system injury; neurons; fibroblast growth factor receptors; biocompatability |
| 07/15/2004 | US20040138154 Solid surface for biomolecule delivery and high-throughput assay |
| 07/15/2004 | US20040138152 adriamycin; chemotherapy; sustained release |
| 07/15/2004 | US20040138139 Diaminodicarboxylic acid/peptide gemini surfactants; drug delivery |
| 07/15/2004 | US20040138132 Membrane translocating peptide drug delivery system |
| 07/15/2004 | US20040138123 Fibroblast growth factor peptide fragments having deletions in the amino acid sequences, conjugates with ricin, diphtheria or saporin, and carrier mixtures, used as wound heling agents or antiproliferative agents |
| 07/15/2004 | US20040138102 Use of a substantially cell membrane impermeable compound for treating arthritis |
| 07/15/2004 | US20040138101 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 07/15/2004 | US20040138074 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 07/15/2004 | US20040137622 Modular transfection systems |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137482 Anti-microbial targeting chimeric pharmaceutical |
| 07/15/2004 | US20040137174 Gastric juice-resistant device for releasing mucoadhesive active substance excipients, and method for producing this gastric juice-resistant device |
| 07/15/2004 | US20040137156 for sustained release; compressed tablets/capsules |
| 07/15/2004 | US20040137071 Nanocapsule encapsulation system and method |
| 07/15/2004 | US20040137069 Pirenzepine ophthalmic gel |
| 07/15/2004 | US20040137051 Wound healing compositions and methods of use |
| 07/15/2004 | US20040137050 Linear polyethylenimine-sterol conjugates for gene delivery |
| 07/15/2004 | US20040137049 Amphotericin b aqueous composition |